EarningsQ3 2024 Earnings Report

Arrowhead Pharmaceuticals (ARWR) Q3 2024 Earnings Report

0 Followers

MX:ARWR Q3 2024 EPS Results

Actual EPS-$24.94

Consensus EPS-$9.56

Beat/MissMissed by -$15.38

One Year Ago EPS-$17.35

Actual Revenue$0.00

Expected Revenue$955.61M

Beat/MissMissed by -$955.61M

YoY Revenue Growth-100.00%

QuarterQ3 2024

Date08/08/2024

TimeAfter Close

Conference CallThursday, August 8, 2024

MX:ARWR Upcoming Earnings

Arrowhead Pharmaceuticals's next earnings date is estimated for November 30, 2026, based on past reporting schedules.

MX:ARWR Q3 2024 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 30, 2026	2026 (Q4)	-28.03 / -	-1.988	―
Aug 04, 2026	2026 (Q3)	-23.08 / -24.58	-22.772	-7.94% (-1.81)
May 07, 2026	2026 (Q2)	-19.79 / -16.81	49.702	-133.82% (-66.51)
Feb 05, 2026	2026 (Q1)	0.67 / 3.98	-25.122	115.83% (+29.10)
Nov 25, 2025	2025 (Q4)	-2.02 / -1.99	-24.58	91.91% (+22.59)
Aug 07, 2025	2025 (Q3)	-17.21 / -22.77	-24.941	8.70% (+2.17)
May 12, 2025	2025 (Q2)	-3.38 / 49.70	-18.435	369.61% (+68.14)
Feb 10, 2025	2025 (Q1)	-8.60 / -25.12	-22.411	-12.10% (-2.71)
Nov 26, 2024	2024 (Q4)	-20.24 / -24.58	-18.435	-33.33% (-6.14)
Aug 08, 2024	2024 (Q3)	-9.56 / -24.94	-17.35	-43.75% (-7.59)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed